levoFLOXacin
Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LevoFLOXacin | SOLUTION, INTRAVENOUS | 5 mg/mL-5% (100 mL) | ||||||||||||||
LevoFLOXacin | SOLUTION, INTRAVENOUS | 5 mg/mL-5% (50 mL) | ||||||||||||||
LevoFLOXacin | SOLUTION, INTRAVENOUS | 5 mg/mL-5% (150 mL) | ||||||||||||||
LevoFLOXacin | SOLUTION, INTRAVENOUS | 5 mg/mL-5% (250 mL) | ||||||||||||||
LevoFLOXacin | SOLUTION, INTRAVENOUS | 25 mg/mL (20 mL) | ||||||||||||||
LevoFLOXacin | SOLUTION, ORAL | 25 mg/mL (480 mL) | ||||||||||||||
LevoFLOXacin | SOLUTION, ORAL | 25 mg/mL (100 mL) | ||||||||||||||
LevoFLOXacin | SOLUTION, ORAL | 25 mg/mL (200 mL) | ||||||||||||||
LevoFLOXacin | TABLET, ORAL | 250 mg | ||||||||||||||
LevoFLOXacin | TABLET, ORAL | 500 mg | ||||||||||||||
LevoFLOXacin | TABLET, ORAL | 750 mg |
UNC Health
UNC Health IV Compendium Guideline
Johnston
Johnston Formulary Restrictions
IV to PO Substitution Policy
Pardee
Automatic IV to PO Conversion Procedure
Rex
Rex Therapeutic Interchange
Anti-Infective Renal Dose Adjustment Policy
Automatic Intravenous to Oral/Enteral (IV to PO) Medication Conversion Policy
Rockingham
Therapeutic Interchange Policy